Delivering Scalable FSP Solutions for a Top 20 Global Pharmaceutical Company 

1 minute read

Published: June 26th, 2025

When a top 20 global pharmaceutical company issued a competitive RFP seeking support in statistical programming and data management, Phastar was selected as a trusted FSP partner. Since 2020, the partnership has grown significantly, with over 100 Phastar professionals now supporting global clinical research efforts across multiple therapeutic areas.

Case Study Highlights:

  • 30% cost reduction through optimized offshore resourcing
  • 28-day average to fill open roles, with new hires adding value from day one
  • Ongoing collaboration via Executive Steering Committees
  • Scalable support across oncology, rare diseases, vaccines, and more

Entering its sixth year, this partnership reflects the strength and sustainability of Phastar’s FSP models. Our tailored FSP solutions continue to support this global pharmaceutical company in driving operational efficiency and clinical success.

Download the full case study to learn how our flexible, high-performance FSP model is helping global pharma sponsors transform clinical trial delivery.

Related articles

Efficient Project Management for a Late-Stage Parkinson’s Disease Study 

Efficient Project Management for a Late-Stage Parkinson’s Disease Study 

January 6th, 2026 1 minute read

Phastar partnered with a biotechnology sponsor to manage statistical and data management activities for a late-stage ...

Turning Legacy Complexity into Submission-Ready Confidence

Turning Legacy Complexity into Submission-Ready Confidence

November 24th, 2025 1 minute read

Discover how Phastar converted 16 legacy studies into SDTM and delivered a robust Integrated Summary of Safety (ISS) ...

Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies 

Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies 

November 17th, 2025 1 minute read

A sponsor needed to pool data from four MS spasticity studies—one still ongoing with another vendor—while adapting mi...